BOSTON SCIENTIFIC CORPORATION Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31)
BOSTON SCIENTIFIC CORPORATION (BSX) had Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) of $274.00 million as of 2013-11-01, per its 10-K filed 2014-02-26.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid · last filed 2014-02-26
- 2013-11-01: Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) $274.00M.
- 2012-11-19: Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) $125.00M; Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) as first filed $300.00M.
- 2012-10-08: Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) $90.00M.
- 2012-10-04: Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) $20.00M.
| Period end | Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) | Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2013-11-01 | $274.00M 10-K · filed 2014-02-26 | |
| 2012-11-19 | $125.00M 10-K · filed 2014-02-26 | $300.00M 10-K · filed 2013-02-22 |
| 2012-10-08 | $90.00M 10-K · filed 2014-02-26 | |
| 2012-10-04 | $20.00M 10-K · filed 2014-02-26 | |
| 2010-11-03 | $5.00M 8-K · filed 2013-05-29 | |
| 2010-10-26 | $194.00M 8-K · filed 2013-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |